Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on ASC. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107602570A reveals efficient Ugi-based synthesis for nitrogenous heterocycles, offering cost reduction and scalable supply chain solutions for pharmaceutical intermediates.
Novel glucose-based route for trifluoromethyl triazoles offers mild conditions and high efficiency for pharmaceutical intermediate manufacturing.
Patent CN113880781B reveals glucose-based synthesis for triazoles offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN115353511A details a safe, multi-component synthesis of carbonyl-bridged biheterocycles using formic acid as a CO source, offering significant cost reduction in API manufacturing.
Patent CN105418710B reveals a cost-effective route for 2,6-Dichloropurine Nucleoside. Enhance supply chain reliability with scalable pharmaceutical intermediates.
Patent CN114163436A details a Pd-catalyzed route for indolizine-diarylmethanes. Delivers high-purity API intermediates with scalable cost reduction strategies.
Patent CN115353511A details a safe, multi-component synthesis of carbonyl-bridged biheterocycles using formic acid as a CO source, offering significant cost reduction in API manufacturing.
Novel glucose-based route for trifluoromethyl triazoles offering cost reduction and scalable manufacturing for pharmaceutical intermediates supply chains.
Patent CN115353511A details a novel Pd-catalyzed multi-component synthesis for carbonyl-bridged biheterocycles, offering safer conditions and cost reduction in API manufacturing.
Patent CN113880781B reveals glucose-based synthesis for trifluoromethyl triazoles. Offers cost reduction in fine chemical manufacturing and reliable pharmaceutical intermediates supplier capabilities.
Novel glucose-based route for triazoles offers cost-effective, scalable, mild conditions for high-purity pharmaceutical intermediates manufacturing.
Patent CN115353511A details a novel Pd-catalyzed multicomponent route for carbonyl-bridged biheterocycles, offering safer processing and cost reduction in API manufacturing.
Patent CN113880781A reveals a novel glucose-based route for 3-trifluoromethyl-1,2,4-triazoles, offering significant cost reduction in API manufacturing and scalable green chemistry.
Patent CN113880781B details biomass-based synthesis. Offers cost reduction and supply chain stability for pharmaceutical intermediate manufacturing globally.
Novel glucose-based route for trifluoromethyl triazoles. Mild conditions, scalable, cost-effective pharmaceutical intermediates manufacturing solution.
Patent CN113880781B details glucose-based synthesis for triazoles. Offers mild conditions and scalable routes for pharmaceutical intermediates supply chains.
Patent CN112480015B details a novel Pd-catalyzed one-pot method for quinazolinones, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel method uses glucose as carbon source for triazole synthesis. Offers mild conditions and high efficiency for reliable pharmaceutical intermediate supply chains.
Novel synthesis of Danshensu Isopropyl Ester via Darzens epoxidation ensures high purity and yield. Reliable supply chain partner for cardiovascular drug intermediates.
Patent CN115353511A details a safe, multi-component synthesis of indolinone-imidazole derivatives using in-situ CO generation, offering significant cost reduction in API manufacturing.